HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer

• Brenda C. O'Connell ,

  * E-mail: brenda.oconnell@infi.com

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Katie O'Callaghan,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Bonnie Tillotson,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Mark Douglas,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Nafeeza Hafeez,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Kip A. West,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Howard Stern,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Janid A. Ali,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Paul Changelian,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Christian C. Fritz,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Vito J. Palombella,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Karen McGovern,

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯
• Jeffery L. Kutok

  Affiliation Infinity Pharmaceuticals, Inc., Cambridge, MA, United States of America

  ⨯